| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 09/18/2008 | US20080227737 Comprises nucleotide sequences for use as diagnostic tools in identifying allelic sequences associated with blood sugar defects |
| 09/18/2008 | US20080227736 Used to transduce heterologous genes into a cell and can be used for in vivo and ex vivo therapeutic applications, as well as for diagnostic and research tool applications |
| 09/18/2008 | US20080227735 Nucleic acid is contactd with cells not expressing receptor protein-tyrosine kinase or expressing it in a nonactivated form (CN cells), contacting first subset S1 of nucleic acids with Ci cells, contacting second subset S2 with CTe cells, amplifying nucleic acids; identifying ligands or aptamers |
| 09/18/2008 | US20080227734 Mutant Lrp5/6 Wnt-Signaling Receptors in Cancer Diagnosis, Prognosis, and Treatment |
| 09/18/2008 | US20080227712 Polypeptide for use in treatment and prevention of leukemia, hemophilia and nervous system disorders |
| 09/18/2008 | US20080227709 Gene expression in peripheral blood mononuclear cells from children with diabetes |
| 09/18/2008 | US20080227703 neublastin neurotrophic factor polypeptides for treating neuropathy |
| 09/18/2008 | US20080227700 contacting the protein with a polypeptide up to about 50 amino acids in length having molecular chaperone activity; protein conformation disease is Alexander's disease, Alzheimer's disease, Creutzfeld-Jakob disease, Parkinson's disease, Huntington's disease, cataract, retinitis pigmentosa, prion disease |
| 09/18/2008 | US20080227695 reduced expression and/or function of Dlg (discs large) is an important factor for tumor formation; measuring the expression and/or function of Dlg |
| 09/18/2008 | US20080227689 Autoimmune disorders; polypeptide GalNAc transferase 1 (ppGalNAcT-1) suppression; antisense RNA |
| 09/18/2008 | US20080227657 System and method for the preparation of arrays of biological or other molecules |
| 09/18/2008 | US20080227654 Method for sequencing nucleic acid molecules |
| 09/18/2008 | US20080227653 Expression monitoring by hybridization to high density oligonucleotide arrays |
| 09/18/2008 | US20080227652 Dna Array for Analyzing Dna Methylation, Method of Producing the Same and Method of Analyzing Dna Methylation |
| 09/18/2008 | US20080227651 Cyclic voltammetry (CV) for identifying genomic sequence variations and detecting mismatch base pairs, such as single nucleotide polymorphisms |
| 09/18/2008 | US20080227199 Method for simultaneous production of multiple proteins; vectors and cells for use therein |
| 09/18/2008 | US20080227195 Expanding the eukaryotic genetic code |
| 09/18/2008 | US20080227194 Lipolytic enzyme specific antibody for use in diagnosis of pancreatitis |
| 09/18/2008 | US20080227192 Nematode ATP Synthase Subunit E-Like Sequences |
| 09/18/2008 | US20080227185 Diagnostic System for Carrying Out a Nucleic Acid Sequence Amplification and Detection Process |
| 09/18/2008 | US20080227160 Using vector transformation to generate transgenic cells expressing interfering RNA sequences; treatment and prevention of metabolic disorders |
| 09/18/2008 | US20080227157 Nucleic acids encoding fusion proteins based on ribosome-inactivating proteins of the mistletoe Viscum Album |
| 09/18/2008 | US20080227152 In vivo incorporation of unnatural amino acids |
| 09/18/2008 | US20080227151 Method for simultaneous production of multiple proteins; vectors and cells for use therein |
| 09/18/2008 | US20080227142 Invasive chemometry |
| 09/18/2008 | US20080227141 Transfection of vectors coding proteins into prokaryotic host cells, culturing, allowing to produce and accumulate isoprenoids consisting of ubiquinone, vitamin K2, and carotenoid |
| 09/18/2008 | US20080227140 Fluorescence resonance energy transfer; autoimmune disorders; immunosuppression; drug screening |
| 09/18/2008 | US20080227139 System, method and applications involving identification of biological circuits such as neurological characteristics |
| 09/18/2008 | US20080227138 Identifying sclerostin antagonist via abilty to prevent apoptosis; treating osteoporosis |
| 09/18/2008 | US20080227137 Differentiation of primate embryonic stem cells into nervous system tissue; obtain primate embryonic stem cell, propagate in culture containing fibroblast growth factor, recover cells |
| 09/18/2008 | US20080227136 Cell culture improvements |
| 09/18/2008 | US20080227135 Autoimmune Conditions and NADPH Oxidase Defects |
| 09/18/2008 | US20080227134 Glyoxylate assays and their use of inden tifying natural amidated compounds |
| 09/18/2008 | US20080227133 Recombinant klebsiella cleaving enzyme (Kpn1) for use as non-specialized gene cutting tool; gel electrophoresis; point mutations; site-directed mutagenesis |
| 09/18/2008 | US20080227132 Hydrolase Enzymes and Their Use in Kinetic Resolution |
| 09/18/2008 | US20080227131 P38 mitogen activated protein kinase fusion for use as reporter molecule in enzyme activation bioassays |
| 09/18/2008 | US20080227130 Using glycohemoglobin (HbA1c) screen to determine concentration of glycosylated hemoglobin in blood; evaluating and monitoring radiation contact |
| 09/18/2008 | US20080227129 Using multimeric ubiquitin fusion protein as an enzyme activity indicator; destruction of reporter demonstrate enhanced enzyme activity |
| 09/18/2008 | US20080227128 Expression cassette for monitoring transcription in transgene systems |
| 09/18/2008 | US20080227127 Human NK3-Related Prostate Specific Gene-1 |
| 09/18/2008 | US20080227125 Using cardiovascular disorder plasma polypeptides (CPPs) as evaluative tools in detection coronary artery disease |
| 09/18/2008 | US20080227124 Multilayer support of polylactone or polyamide and cationic polymer; bioassay; kits |
| 09/18/2008 | US20080227122 P2y purinergic receptor expression for identifying preneoplastic and neoplastic states |
| 09/18/2008 | US20080227121 Using collagen XIII peptide as evaluative tool in identifying modulators monocyte efflux into interstitial space; treating chronic inflammatory disorders |
| 09/18/2008 | US20080227117 Antitrypsin peptide marker for use in diagnosis and treatment of chronic obstructive pulmonary disease |
| 09/18/2008 | US20080227116 Histaminase Determination |
| 09/18/2008 | US20080227115 Inhibition of cancer metastasis |
| 09/18/2008 | US20080227114 Compositions and methods for modulating c-rel-dependent cytokine production |
| 09/18/2008 | US20080227109 Using variation in human leukocyte antigen as evaluative tool in prediciting negative response to allopurinol drugs; prognosing toxic epidermal necrolysis and/or stevens-johnson syndrome |
| 09/18/2008 | US20080227108 Using variation in internal transcribed spacers-1 as evaluative tool classifying fungal species |
| 09/18/2008 | US20080227107 Compositions and methods for labeling of nucleic acid molecules |
| 09/18/2008 | US20080227106 Compositions and methods for the diagnosis and treatment of tumor |
| 09/18/2008 | US20080227105 Using XIII collagen expression as evaluative tool in detecting autoimmune and neuromuscular disorders |
| 09/18/2008 | US20080227104 Primer, primer set, and nucleic acid amplification method and mutation detection method using the same |
| 09/18/2008 | US20080227103 Method for identification of polynucleotides capable of cleaving target mRNA sequences |
| 09/18/2008 | US20080227102 Methods for Identification of Merle Gene |
| 09/18/2008 | US20080227101 Methods for testing milk |
| 09/18/2008 | US20080227100 METHOD FOR ESTIMATING hERG INHIBITION OF DRUG CANDIDATES USING MULTIVARIATE PROPERTY AND PHARMACOPHORE SAR |
| 09/18/2008 | US20080227099 Assay for identifying modulators of cholesterol efflux; treating cardiovascular disorders |
| 09/18/2008 | US20080227098 Using Claudin-1 gene expresion as evaluative tool in screening for cell proliferative disorders of urogenital system |
| 09/18/2008 | US20080227097 Fluorescent protein and chromoprotein |
| 09/18/2008 | US20080227096 Assay for response to proteasome inhibitors |
| 09/18/2008 | US20080227095 Using particle beam variance as analytical tool in determining orders of preferential nucleotide sequence |
| 09/18/2008 | US20080227094 Measuring amount of marker in sample from lymph nodes for detecting lymph node metastasis of stomach cancer, marker comprising mRNA of cytokeratin 19, judging metastasis on the basis of the obtained quantitative value of the mRNA |
| 09/18/2008 | US20080227093 Membrane protein; point mutations; antibodies; food processing and bitterness; phenotype analysis |
| 09/18/2008 | US20080227092 Aminating reducing sugar; mass spectrometry |
| 09/18/2008 | US20080227091 QTL controlling Sclerotinia stem ROT resistance in soybean |
| 09/18/2008 | US20080227090 Methods, apparatus, and computer programs for verifying the integrity of a probe |
| 09/18/2008 | US20080227089 Using lysosomal-associated membrane protein 3 (LAMP3) gene expression profile as evaluative tool in prediciting atopic diseases; immunotherapy |
| 09/18/2008 | US20080227088 Using histone phosphorylation as evaluative tool in monitoring frequency of DNA breaks associated with smoking tobacco |
| 09/18/2008 | US20080227087 Sequences for detection and identification of methicillin-resistant Staphylococcus aureus (MRSA) of MREJ types xi to xx |
| 09/18/2008 | US20080227086 Test System and Method for the Detection of Analytes |
| 09/18/2008 | US20080227085 Methods and Systems for the Identification of Rna Regulatory Sequences and Compounds that Modulate their Function |
| 09/18/2008 | US20080227084 Using shifit from chemokine receptor 5 to chemokine receptor 4 as evaluative tool in predicting viral disease progression; negative prognosis in monitoring AIDs infection |
| 09/18/2008 | US20080227083 Detecting thrombin and/or kallikren activation via variation in fluorescent resonant energy transfer |
| 09/18/2008 | US20080227082 Method of identifying a mhc class i restricted t cell response |
| 09/18/2008 | US20080226766 Determining susceptibility to periodontitis in a Shih Tzu dog, Yorkshire Terrier dog or a dog of a breed that is genetically related; by use of computer program |
| 09/18/2008 | US20080226720 Cultured cells having a wound healing phenotype, wherein the cells have higher levels of expression of expression of apolipoprotein D, matrix metalloprotease 2, and collagen 3a1 relative to the expression level of Ribosomal protein L32; chronic open lesions slow or resistant to healing; cell therapy |
| 09/18/2008 | US20080226681 Highly Active Glycoproteins-Process Conditions and an Efficient Method for their Production |
| 09/18/2008 | US20080226679 Novel surface exposed proteins from chlamydia pneumoniae |
| 09/18/2008 | US20080226662 Nucleotide sequences coding mammalian immune system modulator (B7-DC) for use in treatment and prevention of viral infcetion a nd cell proliferative disorders; immunotherapy |
| 09/18/2008 | US20080226661 Using immunoaffinity recognition to identify phage clones expressing mycoplasma peptides; developing vaccines for prevention and treatment of contagious bovine pleuropneumonia |
| 09/18/2008 | US20080226656 RG1 antibodies and uses thereof |
| 09/18/2008 | US20080226646 Use of biomolecular targets in the treatment and visualization of tumors |
| 09/18/2008 | US20080226644 Nucleotide sequences coding breast cancer protein (BCMP 101) for use in developing vaccines and immunoglobulin which target and destroy tumor tissues; antitumor agents |
| 09/18/2008 | US20080226643 Compositions and methods for the therapy and diagnosis of breast cancer |
| 09/18/2008 | US20080226642 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 09/18/2008 | US20080226641 Mixture comprising group B streptococcal peptide for use in generating vaccine and immunoglobulins for diagnosis, prevention and treatment of urinary tract infections |
| 09/18/2008 | US20080226640 Mixture comprising serum complement system protein (INSP162) use in preparation of vaccines and antibodies for treatment and prevention of infcetion, cell proliferative, skin, neurodegenerative, bone, inflammatory, respiratory system and autoimmune disorders |
| 09/18/2008 | US20080226631 Methods of modulating cytokine activity; related reagents |
| 09/18/2008 | US20080226620 Polypeptide comprising major histocompatibility complex epitopes for use in targeting and destroying tumor cells |
| 09/18/2008 | US20080226613 Using chronic inflammation as evaluative tool in predicting and detecting metastatic cancer |
| 09/18/2008 | US20080226608 Methods of Isolating and Using Enriched Subpopulations of Bone Marrow Progenitors for the Treatment of Diabetes |
| 09/18/2008 | US20080226601 Herpes Virus-Based Compositions and Methods of Use in the Prenatal and Perinatal Periods |
| 09/18/2008 | US20080226599 Methods of treatment involving p21/CIP1 |
| 09/18/2008 | US20080226594 Culturing circular ssdna viruses for the production of vaccines |
| 09/18/2008 | US20080226563 Non-invasive localization of a light-emitting conjugate in a mammal |
| 09/18/2008 | US20080226560 Supplying cargo compound into cancer cells; cargo compound may be nucleic acids, Dna, Rna |
| 09/18/2008 | US20080226558 Mesoderm and definitive endoderm cell populations |
| 09/18/2008 | US20080226557 Generating light |